The 2010 NCCN Clinical Practice Guidelines in Oncology on Prostate Cancer

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 8, Issue 2, 2010, Pages 145-

  Mohler, James L ^{a,b,c,d,e,f,g,h,i,j}  

^a Department of Urology ^*  (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

^e National Board of Medical Examiners and American Board of Urology   (United States)

^f AMERICAN COLLEGE OF SURGEONS   (United States)

^g NCCN Prostate Cancer Guidelines Panel   (United States)

^h Urology Committee of the Cancer and Leukemia Group B   (United States)

ⁱ Board of Trustees   (United States)

^j American Urological Association   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN THERAPY; BRACHYTHERAPY; CANCER LOCALIZATION; CANCER MORTALITY; EDITORIAL; EXTERNAL BEAM RADIOTHERAPY; HEALTH CARE PERSONNEL; HUMAN; MEDICAL PRACTICE; PHYSICIAN; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PROSTATE CANCER; PROSTATECTOMY;

EID: 77649170747     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2010.0010     Document Type: Editorial

References (1)

1. Klotz L. Point: Active surveillance for favorable risk prostate cancer. J Natl Compr Canc Netw 2007;5:693-698.